Clinical Trial

Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Adults

Study acronym: FOSTA-ARDS
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study is designed to evaluate the safety and efficacy of fostamatinib in hospitalized adult participants with acute respiratory distress syndrome (ARDS).
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2024-08-19; most recent amendment 2026-01-30.
Trial Details
NCT Number NCT06564207
Lead Sponsor Inova Health Care Services
Collaborators: Rigel Pharmaceuticals, Biomedical Advanced Research and Development Authority
Conditions Acute Respiratory Distress Syndrome, ARDS
Enrollment 40 participants
Start Date 2026-08-30
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-02